Your browser doesn't support javascript.
loading
Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials.
Magee, D E; Hird, A E; Klaassen, Z; Sridhar, S S; Nam, R K; Wallis, C J D; Kulkarni, G S.
Afiliación
  • Magee DE; Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada.
  • Hird AE; Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada.
  • Klaassen Z; Division of Urology, Department of Surgery, Medical College of Georgia-Augusta University, Augusta, USA.
  • Sridhar SS; Division of Medical Oncology, Department of Internal Medicine, University Health Network, University of Toronto, Toronto, Canada.
  • Nam RK; Division of Urology, Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Wallis CJD; Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada; Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, USA.
  • Kulkarni GS; Division of Urology, Department of Surgery, University Health Network, University of Toronto, Toronto, Canada. Electronic address: Girish.Kulkarni@uhn.ca.
Ann Oncol ; 31(1): 50-60, 2020 01.
Article en En | MEDLINE | ID: mdl-31912796
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Canadá